Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index-Reference-Cited by-同舟云学术

Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index

Published:2018-10 Issue:4 Volume:200 Page:758-766
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Aminsharifi Alireza¹²,Howard Lauren¹³,Wu Yuan¹⁴,De Hoedt Amanda³,Bailey Charlotte³,Freedland Stephen J.³⁵,Polascik Thomas J.¹³

Affiliation:

1. Duke Cancer Institute, Durham, North Carolina

2. Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran

3. Durham Veterans Affairs Medical Center, Durham, North Carolina

4. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina

5. Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. Prostate specific antigen: a decade of discovery—what we have learned and where we are going;Polascik;J Urol,1999

2. Loeb S and Eastham J: Diagnosis and staging of prostate cancer. In: Campbell-Walsh Urology, 11th ed. Edited by AJ Wein, LR Kavoussi, AW Partin et al. Philadelphia: Saunders Elsevier 2016; chap 111, pp 2601-2608.

3. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen;Vickers;BMC Med,2014

4. Utility of digital rectal examination as an adjunct to prostate specific antigen in the detection of clinically significant prostate cancer;Halpern;J Urol,2018

5. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort;Cooperberg;Eur Urol,2015

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era;World Journal of Urology;2024-08-14

2. Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement;Urologic Oncology: Seminars and Original Investigations;2024-07

3. Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata;The Prostate;2024-06-20

4. Hybrid Machine Learning Algorithms to Evaluate Prostate Cancer;Algorithms;2024-06-02

5. A Comparison of Systematic, Targeted, and Combined Biopsy Using Machine Learning for Prediction of Prostate Cancer Risk: A Multi-Center Study;Medical Principles and Practice;2024